Cytotoxic activity against vincristine-resistant human oral epidermoid carcinoma cell line (KB/VJ300)
CC(C1CC2CC3(C1N(C2=O)CCC4=C3NC5=CC=CC=C45)C(=O)OC)O,25
CC(=O)C1CC2CC3(C1NCCC4=C3N(C2O)C5=CC=CC=C45)C(=O)OC,2
CCOC1C2CC(C3N1CCC4=C(C3(C2)C(=O)OC)NC5=CC=CC=C45)C(C)O,25
CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC)O,25
CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC,2.6
CC(C1CC2CC3C1N(C2)CCC4=C3NC5=CC=CC=C45)O,7.8
CCC1CC2CC3(C1N(C2=O)CCC4=C3NC5=CC=CC=C45)C(=O)OC,25
CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC)O,3.5
CCC1CC2CC3(C1N(C2OCC)CCC4=C3NC5=CC=CC=C45)C(=O)OC,13
CC1C2CC3CC4(C2N(CCC5=C4N(C3O)C6=CC=CC=C56)CO1)C(=O)OC,4
CCOC1C2CC(C3N1CCC4=C(C3(C2)C(=O)OC)NC5=CC=CC=C45)C(C)O,25
COC(=O)C1(CC23CCCN4C2C5(C1(CC3)N(C6=CC=CC=C65)C(=O)OC)CC4)O,0.64
CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC)(O)O,14.5
CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC)O,8.5
CCC1CC2CC3(C1N(C2C#N)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC,7
CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C,25
CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC,25
CCC1CC2CC3(C1N(C2)CCC4(C3=NC5=CC=CC=C54)O)C(=O)OC,25
CCC1CC2CC3(C1NCCC4=C3N(C2O)C5=CC=CC=C45)C(=O)OC,2.5
CCC1CC2CC3(C1N(C2C#N)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC,1.1
CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC,25
CC1C2CC3CC4(C2N(CCC5=C4N(C3=O)C6=C5C=CC(=C6)OC)CO1)C(=O)OC,25
CCC1CC(CC2(C1NCCC3=C2NC4=CC=CC=C34)C(=O)OC)CO,25
CCC1CC2CC3(C1N(C2C#N)CCC4=C3NC5=CC=CC=C45)C(=O)OC,1.4
CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC)O,18.8
CC(C1CC2CC3(C1NCCC4=C3N(C2O)C5=C4C=CC(=C5)OC)C(=O)OC)O,25
